The other two variants, NLRP13 and SLCO4C1, are found to be implicated in different types of cancer, diabetes type 2, eye movement dysfunction and obesity (Table 6). This evidence concerns the gene NLRP13 and obesity due to melanocortin 4 receptor deficiency.